Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Operations (2018 - 2025)

Bicycle Therapeutics' Cash from Operations history spans 8 years, with the latest figure at 19346000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 105.9% year-over-year to 19346000.0; the TTM value through Dec 2025 reached 249675000.0, down 51.57%, while the annual FY2025 figure was 249675000.0, 51.57% down from the prior year.
  • Cash from Operations reached 19346000.0 in Q4 2025 per BCYC's latest filing, up from 71173000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 34096000.0 in Q2 2023 to a low of 86370000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 28796600.0, with a median of 24965500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: surged 317.51% in 2021, then tumbled 3786.05% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 10435000.0 in 2021, then tumbled by 190.46% to 30309000.0 in 2022, then crashed by 56.02% to 47288000.0 in 2023, then skyrocketed by 80.13% to 9396000.0 in 2024, then tumbled by 105.9% to 19346000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Cash from Operations are 19346000.0 (Q4 2025), 71173000.0 (Q3 2025), and 72786000.0 (Q2 2025).